An HIV 1 and 2 antigen test (fourth‑generation) detects HIV‑1 p24 antigen and antibodies to HIV‑1 and HIV‑2 in blood. By identifying p24 antigen it shortens the window period, enabling earlier detection than antibody‑only tests. It's used for screening; reactive results require confirmatory testing and follow‑up to distinguish acute infection and determine the specific HIV type.

A positive HIV‑1 and HIV‑2 antibody test means antibodies to HIV were detected, strongly suggesting infection. Because false positives can occur, a reactive result needs confirmatory testing (antigen/antibody assay and/or RNA PCR). If confirmed, prompt medical evaluation for viral load, CD4 count, and antiretroviral therapy is recommended. Seek counseling and avoid behaviors that could transmit HIV until diagnosis is confirmed.

Non-reactive for HIV‑1 and HIV‑2 means no HIV antibodies or antigens were detected, so the result is likely negative. If you had recent exposure, repeat testing after the window period—generally 4–6 weeks and sometimes again at 3 months—because early infection can be missed. If exposure was within 72 hours, seek urgent advice about post‑exposure prophylaxis.

HIV‑1 is generally worse: it’s more common worldwide, more transmissible, and tends to replicate faster, causing quicker progression to AIDS. HIV‑2 is less contagious, usually progresses more slowly and is largely concentrated in West Africa, but can still cause AIDS. Both require diagnosis and antiretroviral treatment; management differs slightly and should be guided by healthcare providers.

HIV‑1 and HIV‑2 are not curable. Antiretroviral therapy (ART) can suppress viral replication to undetectable levels, keeping people healthy and preventing transmission, but it must be taken lifelong. Very rare cases of apparent cure followed complex bone marrow transplants and are not generalizable. Early diagnosis, continuous ART, and prevention measures remain essential for managing both HIV‑1 and HIV‑2.

“Normal” for HIV‑1/2 screening is a non‑reactive (negative) antigen/antibody test. For viral load, normal (no detectable virus) is reported as undetectable—typically below about 20–50 copies/mL depending on the assay; viral suppression is often defined as <200 copies/mL. CD4 counts in uninfected adults commonly range roughly 500–1,600 cells/mm3. Reactive results require confirmatory testing and clinical follow‑up.